Reducing Cardiovascular Risk
in the Diabetic Patient

This webcast series presents molecular insights of diabetes in atherosclerosis, glucose lowering and cardiovascular risk reduction, and intensive lipid modification in diabetic patients.

Target Audience

This series is intended for physicians, nurse practitioners, physician assistants and other interested health care professionals who treat patients with diabetes.

Webcasts
	Molecular Insights into the Role of Diabetes in Atherosclerosis and Glucose Lowering and Cardiovascular Risk Reduction: Are We Failing?
	Estimated Time: 30 minutes Release Date: February 14, 2011 Type: Webcast	Technical Requirements: Flash Player Expiration Date: February 14, 2012 Specialties: Cardiology, Endocrinology
	Intensive Lipid Modification in the Diabetic Patient and Plaque Progression in Diabetic Patients: Insights from Arterial Wall Imaging
	Estimated Time: 30 minutes Release Date: February 14, 2011 Type: Webcast	Technical Requirements: Flash Player Expiration Date: February 14, 2012 Specialties: Cardiology, Endocrinology
	Can We Develop a Viable PPAR Agonist for Diabetic Patients? and Challenges in Developing New Therapies for Risk Reduction in Diabetes
	Estimated Time: 30 minutes Release Date: February 14, 2011 Type: Webcast	Technical Requirements: Flash Player Expiration Date: February 14, 2012 Specialties: Cardiology, Endocrinology

Series Objectives

1. Describe benefits of intensive lipid lowering therapy as it applies to CVD risk reduction in patients with diabetes.
2. Discuss clinical evidence supporting use of intensive treatment to reduce HbA1c levels.
3. Summarize the most recent molecular research on the role of diabetes in atherosclerosis and arterial stenosis.
4. Compare and contrast the efficacy and side effect data from recent diabetes intervention studies for reducing CVD risk in patients with diabetes and identifying potential therapeutic targets.

Activity Directors

Accreditation

These activities have been approved for AMA PRA Category 1 Credit™